HomeNewsVideosBusinessStocksGland Pharma | Growth momentum in US business may help re-rate | Stock Of The Day

Trending Topics

Sensex Live

Pine Labs Share Price

Tenneco Clean Air India IPO

Groww IPO

Gold Rate

Gland Pharma | Growth momentum in US business may help re-rate | Stock Of The Day

Incorporated in 1978 and promoted by Fosun Pharma, Gland Pharma is a strong play on global generic injectables. It operates on B2B model with leading pharmaceutical companies such as Sagent, Apotex, Fresenius Kabi and Athenex. It has eight manufacturing plants and have a capacity to manufacture about 100 crore formulation units per annum.

Moneycontrol News

TAGS: #Stocks to buy #Stocks to Watch #top stock #trending stocks stock market #video

first published: Sep 20, 2023 12:25 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On:

instagram

youtube

News

Business New Market New Stocks Income Tax Calculator Election Schedule 2024 India News Economy Mutual Funds Personal Finance IPO News Startups New USA Elections New

Features

Gold Rate Today Silver Rate Today Trending News Startups New National News MC Videos MC You Tube

Tools

SIP Calculator 2 SIP Calculator 3 SIP Calculator 1 New SIP Calculator 4

Specials

PowerYourTrade Master Your Money Game Changers

Network 18 Sites

News18 Firstpost CNN News18 CNBC TV18 Forbes History TV18

Personal Finance

Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker Fixed Deposits Fixed Deposit Comparison Fixed Income Account Aggregator

Quick Links

About Us New Contact Us Advisory Alert New Advertise with Us New Disclaimer Privacy Policy Cookie Policy Terms & Conditions Careers Financial Terms (Glossary) Analytical & Information Tool New

Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.